Clinical validation of the CD32b biomarker on the European market

Louise Bowman

Large randomised clinical trials in other (non-vascular) conditions

Leukaemia

Pediatric oncology or childhood cancer

James You

Role of MicroRNAs in the Tumorigenesis of T-ALL

Leukaemia

Hematology and hematologic malignancies Pathology

Seth J Corey

Genetic Modifiers for Cancer Stem Cells in Secondary MDS/AML

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Markus Muschen

Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia

Trachea, bronchus and lung Leukaemia Breast

Genoveffa Franchini

T-Cell Transformation by Oncoviruses

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Aplan

Collaborative Pathways that Lead to Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Hugh-George G Patterton

Reprogramming of the Trypanosoma brucei epigenome during human infection

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Nkiru Odunukwe

National Multiple Myeloma Survey: Prevalence and Treatment Outcomes in Nigeria

Leukaemia

Hematology and hematologic malignancies